About Pharmatrain
The main objective of the PharmaTrain project is to build and implement a new modular Master level programme for advanced studies in Pharmaceutical Medicine and Drug Development Sciences. The programme is based on the Bologna credit and title system and builds on the new PharmaTrain Syllabus 2010 of the European Federation of Courses in Pharmaceutical Medicine (EFCPM). The modular concept of the training programme also provides an opportunity to professionals to select courses for accredited Continued Professional Development (CPD), as well as individualised training à la carte. The PharmaTrain consortium has identified six base courses and 13 master level programmes at European universities that will be harmonised at a high quality level. PharmaTrain will set, maintain and constantly improve the standards and quality management of the training schemes and practices for professionals working in drug development. The programme will encourage exchanges between the industry, regulators and academia, produce and promote distance e-learning programmes, and will enable increased flexibility, transferability and mobility. By providing a chart of available and planned training programmes at the different levels across Europe, PharmaTrain will identify the regions with the unmet needs and plan the pan-European expansion accordingly.
A uniform high-level training in Europe will make the drug development process faster, more economical, more tailored to patients’ needs, and will give Europe a global advantage in developing new innovative medicines. PharmaTrain is a collaboration of 25 EFCPM university training units, 13 learned societies including three regulatory agencies, several other partner training organisations and 15 member companies from the European Federation of Pharmaceutical Industries and Associations (EFPIA).
First year achievements include a standardised Syllabus with worldwide impact since it is foreseen to be adopted by IFAPP and the Faculty of Pharmaceutical Medicine, Royal College, UK, draft programme learning outcomes, a draft concept for a modular curriculum, an agreed principle of unified examination, a programme for evaluating different mixes of blended e-learning during the programme, a draft concept of cooperative training among new EU member states involving some additional 15 affiliated universities, a concept for a pan-European accreditation system, a draft Continued Professional Development (CPD) Platform and a draft comprehensive quality management process.
A uniform high-level training in Europe will make the drug development process faster, more economical, more tailored to patients’ needs, and will give Europe a global advantage in developing new innovative medicines. PharmaTrain is a collaboration of 25 EFCPM university training units, 13 learned societies including three regulatory agencies, several other partner training organisations and 15 member companies from the European Federation of Pharmaceutical Industries and Associations (EFPIA).
First year achievements include a standardised Syllabus with worldwide impact since it is foreseen to be adopted by IFAPP and the Faculty of Pharmaceutical Medicine, Royal College, UK, draft programme learning outcomes, a draft concept for a modular curriculum, an agreed principle of unified examination, a programme for evaluating different mixes of blended e-learning during the programme, a draft concept of cooperative training among new EU member states involving some additional 15 affiliated universities, a concept for a pan-European accreditation system, a draft Continued Professional Development (CPD) Platform and a draft comprehensive quality management process.